Patent · US Active

Heteroaromatic compounds as BTK inhibitors

US9975882B2 · kind B2 · utility

3Cited by

3References

40Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Todd Bosanac · New Milford, US
Joerg Bentzien · White Plains, US
Michael J. Burke · West Haven, US
Ryan Michael FRYER · Brewster, US
Eric T. Larson · Bethel, US
Wang Mao · Milford, US
Bryan McKibben · White Plains, US
Yue Shen · Berlin, US
Fariba Soleymanzadeh · Brewster, US
Matt Aaron Tschantz · Newtown, US

Key dates

Filing date	Dec 15, 2016
Grant date	May 22, 2018
Priority date	—
Expiry date	Dec 15, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention encompasses compounds of the formula (I)wherein the groups R1, Cy and Y are defined herein, which are suitable for the treatment of diseases related to BTK, and processes for making these compounds, pharmaceutical preparations containing these compounds, and their methods of use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.